BMS Furthers its Immuno-Oncology Pipeline with Nearly $1.6 Billion in Investments
Bristol-Myers Squibb announced that it reached an agreement to acquire Flexus Biosciences and has entered into a $309-million partnership with Rigel Pharmaceuticals.

Valeant Acquires Salix for $14.5 Billion
Valeant announced that it acquired Salix Pharmaceuticals for approximately $14.5 billion, which could result in annual cost savings of $500 million.

Manufacturers Weigh Strategies to Prevent Drug Shortages
Drug shortages are declining, but they're still a serious concern for regulatory authorities, policy makers, and bio/pharmaceutical manufacturers.

Sagent Pharmaceuticals Recalls Atracurium Besylate Injection
The company voluntarily recalls product due to FDA observations of potential sterility problems.

Advertisement: Enhancing Quality and Process Efficiency using Continuous Manufacturing Technology for Drug Substance and Drug Product On Demand Click here to Register free.

FDA Issues Warning Letter to India Facility
The agency cites Apotex's Bangalore facility with quality system failures.

Kite Pharma Expands Manufacturing for T-Cell Therapies
Leased facilities in California will expand Kite Pharma's capacity for clinical T-cell therapies.

Advertisement: Pharma Supply Chain Security: Are You in Control? Live broadcast on: March 19th, 2015 at 11AM ET Spray-dried dispersion technology is a proven approach to improve the dissolution rate and bioavailability of low solubility compounds, and helps to bring new medicines to market. Attend this webinar to learn the fundamentals of spray-dried dispersion formulation selection, process development, stability, scale-up, and performance considerations. Learn More

Revlimid Gains FDA Approval for NDMM Patients
Celgene announced that its drug, Revlimid, gained FDA approval for the treatment of newly diagnosed multiple myeloma.

Sanofi Appoints Bayer's Brandicourt as New CEO
Brandicourt will leave Bayer HealthCare AG to begin his new role as CEO of Sanofi in April 2015.

Is It Time to Ditch QbD for Development by Design? Questions From a QbD Cheerleader
QbD represents a breakthrough in thinking, but does it go far enough to address today's business challenges?

EMA Establishes Drug Identification Task Force
The agency is enlisting members of European pharmaceutical associations and industry representatives to participate in IDMP task force.

Siegfried Announces Resolution of Hameln Pharma Regulatory Issues
The company announces that FDA has closed out a 2012 warning letter.

NIST Partners with MedImmune on Protein Characterization Venture
MedImmune will provide funds and access to monoclonal antibodies to seven postdoctoral associates for the creation of protein measurement and characterization tools.

Johnson & Johnson's Remicade Patent Invalidated
The Patent and Trademark Office sends notice rejection of the company's Remicade patent.